Intelligence Platform

Patents

Browse 837 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6627415

TIE-2 ligands, methods of making and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610510

Morphogenic proteins

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6602683

Biologically active Eph family ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6602687

DNA encoding human ciliary neurotrophic factor and method for producing the protein encode

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6472179

Receptor based antagonists and methods of making and using

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6472178

Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6455035

Angiopoietins and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6440702

Nucleic acids encoding modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6441137

Expressed ligand-vascular intercellular signalling molecule

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6432667

Polynucleotide encoding TIE-2 ligand-4

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6433143

Tie-2 ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6413740

Tyrosine kinase receptors and ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6410510

Administration modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6316206

Method for screening comprising cells expressing the CNTF receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6265564

Expressed ligand-vascular intercellular signalling molecule

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6207413

Nucleic acids encoding novel orphan cytokine receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6166185

Antibodies to human TIE-2 ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6143714

Methods of using hepatocyte growth factor to promote survival, growth and differentiation

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6077829

Stable pharmaceutical composition of BDNF

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 20 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060276

Nucleic acids encoding novel orphan cytokine receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6022694

Assay for ligands to tyrosine kinase receptors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired